JPRN-jRCT1090220212
Completed
未知
Prospective observational study of SGLT2 inhibitor, tofogliflozin in patients with type 2 diabetes - Prospective observational study of tofogliflozin in patients with type 2 diabetes
agoya Medical Association0 sites600 target enrollmentApril 8, 2015
ConditionsType 2 Diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes
- Sponsor
- agoya Medical Association
- Enrollment
- 600
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\*Patients with type 2 diabetes
- •\*Age 20 years or older
- •\*The patients that diabetes treatment does not have a change more than the past two months
- •\* In more than 6\.0% and regulation are less than \+\-10% of patients each HbA1c of most recent two times
- •\*Ability to give written informed consent
Exclusion Criteria
- •\*Patients with type 1 diabetes
- •\*History of severe ketosis, diabetic coma or previous coma within 6 months
- •\*Patients with severe infectious disease ,before or after surgery, or sever trauma
- •\*Occurrence of stroke, myocardial infarction or vascular complication required hospitalization within 6 months
- •\*Under treatment with SGLT\-2 inhibitors
- •\*Pregnant, women on lactation or possibly pregnant women, or plan to pregnant during the study
- •\*History of hypersensitivity to tofogliflozin
- •\*Ineligible patients according to the investigator's judgment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indicesdiabetes mellitusJPRN-UMIN000050228agoya University4,250
Recruiting
Phase 4
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseType 2 Diabetes MellitusObesityC06.552.241.519C18.452.394.750.149RBR-48rxwbCentro Educacional Hyarte
Completed
Not Applicable
Prospective intervention study of novel SGLT-2 inhibitor ipragliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015104Seino Naika Clinic100
Completed
Not Applicable
ong-term efficacy and safety of the SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.JPRN-UMIN000037872akakinen Clinic630
Completed
Not Applicable
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16